Omaha, NENCT04558541Now EnrollingIRB Ready

Developmental Language Disorder Clinical Trial in Omaha, NE

Access cutting-edge developmental language disorder treatment through this clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.

Sponsored by Father Flanagan's Boys' Home

Quick Self-Assessment

See if you qualify for this Omaha location

Preparing your pre-screening questions…

Expert Care in Omaha

Access developmental language disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related developmental language disorder treatment provided free

Apply for This Omaha Location

Check if you qualify for this developmental language disorder clinical trial in Omaha, NE

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Omaha

    Convenient for NE residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Omaha site if eligible
  4. 4Begin participation

About This Developmental Language Disorder Study in Omaha

The broad aim of this clinical study is to assess the hypothesis that morphological and phonological deficits are linked by a broader deficit in sequential pattern learning. This hypothesis applies to learning in general, but is especially critical as an avenue for developing earlier assessments and more powerful interventions for children with developmental language disorder (DLD; also known as specific language impairment). Other populations, such as at-risk toddlers, may also benefit from this new approach.

Sponsor: Father Flanagan's Boys' Home

Who Can Participate

Inclusion Criteria

Because clinical precision is required, 4- to 8-year-olds will complete a large test battery.
All children (TD, DLD, DLD + SSD, SSD) will score above 75 on the Nonverbal Scale of the Kaufman Assessment Battery for Children (KABC-II), which is above the Diagnostic and Statistical Manual cut-off for intellectual disability, even considering the standard error of measurement.
Hearing will be within normal limits
Oral structures will be within normal limits (Robbins \& Klee, 1987).
The Childhood Autism Rating Scale (Schopler et al., 2010) and parent report, will be used to rule out autism. Children with DLD will meet standard criteria.
Children with DLD will score below the cutoff of 87 on the Structured Photographic Expressive Language Test-P2 (SPELT-P2; Dawson et al., 2005) that has demonstrated high diagnostic accuracy for DLD.
Children with DLD will perform below 80% in their spontaneous production of finite verb morphemes.
Performance on a nonword repetition task will also support DLD status. Scores below 70% for total phonemes correct across all nonword lengths are greater than 1 SD below the mean for typical children.
Speech production skills will be measured via the Goldman-Fristoe Test of Articulation-3 (GFTA-3; Goldman \& Fristoe, 2015) and the inconsistency subtest of the Diagnostic Evaluation of Articulation and Phonology (DEAP, Dodd, et al., 2006). Many 4- to 6-year-old children with DLD are expected to perform below expected levels on the GFTA-3; for this study half of the children with DLD will show performance below expected levels and half above a standard score of 85. Children with SSD will show impaired performance on the GFTA-3, but typical performance on grammatically weighted language measures (SPELT-P2 and finite verb morphemes). The DEAP serves as a standardized measure of segmental inconsistency and will provide a post hoc analysis that may be related to sequence pattern variability. Performance on the following measures will serve as covariates and will not be

Exclusion Criteria

ary for DLD or SSD:
Peabody Picture Vocabulary Test, 4th ed (Dunn \& Dunn, 1997)
Expressive Vocabulary Test, 2nd ed (Williams, 1997)
Verbal and nonverbal memory span.
Because of the emphasis on English phonological and morpho-syntactic patterns, all participants will be monolingual English learners or report dominant exposure to English from infancy. Exposure to other languages will be documented. Exclusion Criteria for all participants:
Hearing impairment
Intellectual impairment
Significant motor impairment. Typical participants will be excluded if they show: -Histories of developmental, speech, language, or hearing disorders.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Omaha?

Yes, this clinical trial (NCT04558541) has an active research site in Omaha, NE that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Developmental Language Disorder Treatment Options in Omaha, NE

If you're searching for developmental language disorder treatment options in Omaha, NE, this clinical trial (NCT04558541) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Omaha research site is actively enrolling participants for this clinical trial. You'll receive care from experienced developmental language disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all developmental language disorder clinical trials near you to find additional studies recruiting in your area.

More Myalgic Encephalomyelitis Trials in Omaha, NE

See all myalgic encephalomyelitis clinical trials recruiting in Omaha — not just this study.

Browse Myalgic Encephalomyelitis Trials in Omaha →

Browse More Trials by Condition

Myalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Omaha?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Omaha, NE